Glaucoma and ocular hypertension: The importance of intraocular pressure in treatment decisions in France;Glaucome et hypertonie oculaire: Importance de la pression intraoculaire cible dans la prise en charge thérapeutique en France

Journal Francais d'Ophtalmologie

Volumn 26, Issue 9, 2003, Pages 895-903

  Bron, A ^a   Nordmann, J P ^b   Baudouin, C ^b   Rouland, J F ^c   Kadi, A ^d   Sartral, M ^d  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d Laboratoire Pharmacia   (France)

Author keywords

Intraocular pressure; Ocular hypertension; Open angle glaucoma

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROSTAGLANDIN;

ADULT; AGE DISTRIBUTION; AGED; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL SPECIALIST; MONOTHERAPY; OPEN ANGLE GLAUCOMA; OPHTHALMOLOGY; REVIEW;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DECISION MAKING; DISEASE PROGRESSION; DRUG MONITORING; FEMALE; FRANCE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MANOMETRY; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMOLOGY; PATIENT COMPLIANCE; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRIVATE PRACTICE; QUESTIONNAIRES; RISK FACTORS; TREATMENT OUTCOME; VISUAL FIELDS;

EID: 0345708402     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Sommer A, Tielsch JM, Katz J et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black americans. The Baltimore eye survey. Arch Ophthalmol, 1991;109:1090-5.
2. Rouland JF, Peigne G, Sellem E et al. Étude observationnelle rétrospective de coûts des deux premières années de traitement dans le glaucome primitif à angle ouvert et l'hypertension oculaire en France. J Fr Ophtalmol, 2001;24:233-43.
3. Bengtsson B. The prevalence of glaucoma. Br J Ophthalmol, 1981;65:46-69.
4. Mitchell P, Smith W, Attebo K, Healey H. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology, 1996;103:1661-9.
5. Bonomi L, Marchini G, Marraffa N et al. Prevalence of glaucoma and intraocular distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology, 1998;105:209-15.
6. Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology, 1994;101:1851-5.
7. Thylefors B, Negret AD, Pararajasegaram R. Epidemiologic aspects of global blindness prevention. Curr Opin Ophthalmol, 1992;3:824-34.
8. The American Academy of Ophthalmology. Preferred practice patterns: primary open angle glaucoma. Guidelines, 1996;187-95.
9. Hertzog LH, Albrecht KG, LaBree L, Lee PP. Glaucoma care and conformance with preferred practice patterns. Examination of the private, community-based ophthalmologist. Ophthalmology, 1996;103:1009-13.
10. Terminology and guidelines for glaucoma. European Glaucoma Society, 1998.
11. Jampel HD. Target pressure in glaucoma therapy. J Glaucoma, 1997;6:133-8.
12. Bito LZ. A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond. Invest Ophthalmol Vis Sci, 2001;42:1126-33.
13. Fraser S, Bunce C, Wormald R. Retrospective analysis of risk factors for late presentation of chronic glaucoma. Br J Ophthalmol, 1999;83:24-8.
14. Sommer A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr Opin Ophthalmol, 1996;7:93-8.
15. Hitchings R, Tan J. Target pressure. J Glaucoma, 2001;10:S68-S70.
16. Singh K, Spaeth G, Zimmerman T, Minckler D. Target pressure-Glaucomatologists'Holey Grail. Ophthalmology, 2000;107:629-30.